Phase 2 Ovarian Cancer Trial, Recruiting NCT06519656 Sponsor: Shanghai Zhongshan Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 2 Ovarian Cancer Trial, Recruiting

NCT06519656
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a Body Mass Index (BMI) of 28 or higher (considered overweight or obese by standard medical charts).
  • You do not plan to become pregnant in the 8 months after joining the trial.
  • You meet at least two of the following three conditions related to PCOS (polycystic ovary syndrome):
    • Your menstrual cycles are irregular — either shorter than 21 days, longer than 35 days, fewer than 8 periods per year, or any single cycle lasting more than 90 days.
    • An ultrasound has shown 20 or more small follicles (fluid-filled sacs) in at least one of your ovaries.
    • A blood test shows higher-than-normal testosterone levels, or a physical assessment shows signs of excess male-pattern hair growth (confirm with trial site).

Who may not be able to join:

  • You have had pancreatitis (inflammation of the pancreas) or a pancreatic injury at any point in your life.
  • You or a close family member has had a specific type of thyroid cancer (medullary thyroid cancer) or a related hormonal condition called multiple endocrine neoplasia type 2a or 2b.
  • Your blood fat (triglyceride) levels are very high (above a certain level confirmed by a blood test).
  • You have been diagnosed with Type 1 or Type 2 diabetes.
  • You have another hormonal or glandular condition that could be causing your PCOS-like symptoms, such as thyroid problems, high prolactin levels, or other hormonal disorders (confirm with trial site).
  • You are currently pregnant or breastfeeding.
  • You have a serious condition affecting your heart, liver, kidneys, or other major organs.
  • You have been diagnosed with any type of cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: XI DONG, MD, Fudan University

Phone: 02164041990

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
21 October 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Free Androgen Index (FAI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov